← Back to patent-cliff list
Tiludronate Disodium Hydrate
Tier C — Watch / tradeTiludronate Disodium Hydrate
Sanofi
Originator
1995
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PTPs
Brand：Skelid
Indications (approved)：Paget's disease
Regional status
US
Withdrawn
EU
Approved
1995-01-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tiludronate Disodium Hydrate?
Approved indications include: Paget's disease.
When does the Tiludronate Disodium Hydrate patent expire?
No public expiry year is available for Tiludronate Disodium Hydrate yet; this page updates once verified.
How do I get a quote for Tiludronate Disodium Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04